血小板与淋巴细胞比值在预测接受醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌患者生存中的预后价值：一项基于证据的病例报告及文献综述
Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature.
作者信息
Yausep Oliver E, Agarwal Raksheeth, Aulina Rifqha, Wijaya Anthony E, Amaia Ilonka, Moekti Addina W, Rinaldi Ikhwan, Hamid Agus Rizal A H
机构信息
Faculty of Medicine University of Indonesia Jakarta Indonesia.
Department of Internal Medicine, Medical Hematology-Oncology Division Cipto Mangunkusumo Hospital Jakarta Indonesia.
出版信息
Clin Case Rep. 2019 Jul 11;7(8):1585-1590. doi: 10.1002/ccr3.2288. eCollection 2019 Aug.
Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.
血小板与淋巴细胞比值（PLR）是接受醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌患者的一个潜在预后标志物，且有证据表明高PLR与较差的生存率相关。需要更多研究来验证当前的研究结果并确定一个明确的临界值。
Zotero 插件